HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Galuppo Selected Research

(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acid

7/2012Peroxisome proliferator-activated receptor β/δ agonist GW0742 ameliorates cerulein- and taurocholate-induced acute pancreatitis in mice.
8/2010GW0742, a selective PPAR-beta/delta agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury.
5/2010Evidence for the role of peroxisome proliferator-activated receptor-beta/delta in the development of spinal cord injury.
4/2010GW0742, a high-affinity PPAR -beta/delta agonist, inhibits acute lung injury in mice.
2/2010Role of PPAR-delta in the development of zymosan-induced multiple organ failure: an experiment mice study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Galuppo Research Topics

Disease

21Inflammation (Inflammations)
11/2017 - 08/2009
12Spinal Cord Injuries (Spinal Cord Injury)
09/2015 - 05/2009
6Reperfusion Injury
11/2015 - 02/2010
5Myelitis
04/2011 - 05/2009
4Multiple Sclerosis
10/2015 - 08/2013
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2015 - 08/2013
4Neurodegenerative Diseases (Neurodegenerative Disease)
10/2015 - 11/2014
4Ischemia
12/2014 - 02/2010
4Shock
11/2010 - 02/2010
3Demyelinating Diseases (Demyelinating Disease)
10/2015 - 06/2014
3Fibrosis (Cirrhosis)
09/2015 - 04/2011
3Edema (Dropsy)
07/2012 - 11/2010
3Body Weight (Weight, Body)
05/2012 - 02/2010
3Multiple Organ Failure (MODS)
09/2011 - 02/2010
3Septic Shock (Toxic Shock Syndrome)
05/2011 - 02/2010
2Neuroinflammatory Diseases
11/2017 - 06/2015
2Brain Ischemia (Cerebral Ischemia)
11/2015 - 12/2014
2Aneurysm (Aneurysms)
11/2013 - 08/2011
2Pancreatitis
07/2012 - 05/2012
2Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2011 - 04/2011
2Pneumonia (Pneumonitis)
07/2011 - 02/2010
2Lung Injury
07/2011 - 04/2011
2Periodontitis
05/2011 - 11/2010
2Pleurisy (Pleuritis)
04/2010 - 02/2010
1Paralysis (Palsy)
10/2015
1Encephalomyelitis (Myeloencephalitis)
10/2015
1Wounds and Injuries (Trauma)
09/2015
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2015
1Vomiting
11/2014
1Glaucoma
11/2014
1Cachexia
11/2014
1Anorexia
11/2014
1Nausea
11/2014
1Mental Disorders (Mental Disorder)
11/2014
1Peripheral Nervous System Diseases (PNS Diseases)
03/2014
1Cardiomyopathies (Cardiomyopathy)
03/2014
1Diabetes Mellitus
03/2014
1Body Weight Changes
09/2013
1Parkinson Disease (Parkinson's Disease)
09/2013

Drug/Important Bio-Agent (IBA)

103-nitrotyrosineIBA
10/2015 - 05/2009
10CytokinesIBA
10/2015 - 05/2009
6thioglucosidaseIBA
11/2015 - 08/2013
6NF-kappa B (NF-kB)IBA
12/2014 - 05/2009
6EnzymesIBA
12/2014 - 11/2010
6Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2014 - 05/2009
5(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
07/2012 - 02/2010
4Neuroprotective AgentsIBA
10/2015 - 04/2011
4GlucocorticoidsIBA
09/2015 - 05/2009
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2015 - 11/2010
4glucoraphaninIBA
12/2014 - 08/2013
4ZymosanIBA
09/2011 - 02/2010
4Peroxidase (Myeloperoxidase)IBA
05/2011 - 02/2010
4Tyrosine (L-Tyrosine)FDA Link
05/2011 - 02/2010
4PPAR-betaIBA
08/2010 - 02/2010
4LigandsIBA
02/2010 - 02/2010
3Caspase 3 (Caspase-3)IBA
10/2015 - 12/2014
34- ((alpha- L- rhamnosyloxy)benzyl)isothiocyanateIBA
01/2015 - 06/2014
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
07/2012 - 05/2009
3Poly Adenosine Diphosphate RiboseIBA
05/2011 - 02/2010
3T0901317IBA
02/2010 - 02/2010
3Liver X ReceptorsIBA
02/2010 - 02/2010
2CannabinoidsIBA
10/2015 - 11/2014
2Therapeutic UsesIBA
10/2015 - 11/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
09/2015 - 05/2009
2isothiocyanic acidIBA
01/2015 - 01/2015
2CeruletideIBA
07/2012 - 05/2012
2Proteins (Proteins, Gene)FDA Link
07/2012 - 09/2011
2Nerve Growth Factors (Neurotrophins)IBA
08/2011 - 04/2011
22- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
07/2011 - 02/2010
2Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
07/2011 - 02/2010
2Bleomycin (Blenoxane)FDA LinkGeneric
07/2011 - 04/2011
2Glutamine (L-Glutamine)FDA Link
05/2011 - 09/2010
2acteosideIBA
05/2011 - 10/2010
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2010 - 02/2010
2CarrageenanIBA
04/2010 - 02/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 10/2009
1IntegrinsIBA
11/2017
1CateninsIBA
11/2017
1CannabidiolIBA
10/2015
1P-SelectinIBA
10/2015
1IsothiocyanatesIBA
10/2015
1Mometasone Furoate (Nasonex)FDA LinkGeneric
09/2015
1Mitogen-Activated Protein Kinase 3IBA
09/2015
1glucose-mannose-glucoseIBA
01/2015
1AntioxidantsIBA
01/2015
1PhytochemicalsIBA
01/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2014
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
11/2014
1Heavy MetalsIBA
11/2014
1NAD (NADH)IBA
03/2014
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
09/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2013

Therapy/Procedure

8Laminectomy
01/2015 - 05/2009
3Therapeutics
06/2015 - 02/2010
2Oral Administration
06/2015 - 05/2011
2Drug Therapy (Chemotherapy)
11/2014 - 05/2011
2Surgical Instruments (Clip)
11/2013 - 08/2011
2Ligation
05/2011 - 11/2010
1Complementary Therapies (Alternative Medicine)
10/2015
1Glycemic Control
03/2014